Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

448 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Longitudinal follow-up of patients with thalassaemia intermedia who started transfusion therapy in adulthood: a cohort study.
Ricchi P, Meloni A, Pistoia L, Spasiano A, Rita Gamberini M, Maggio A, Gerardi C, Messina G, Campisi S, Allò M, Renne S, Righi R, Midiri M, Positano V, Filosa A, Pepe A. Ricchi P, et al. Among authors: midiri m. Br J Haematol. 2020 Oct;191(1):107-114. doi: 10.1111/bjh.16753. Epub 2020 May 19. Br J Haematol. 2020. PMID: 32427352 Free article.
Gender differences in the development of cardiac complications: a multicentre study in a large cohort of thalassaemia major patients to optimize the timing of cardiac follow-up.
Pepe A, Gamberini MR, Missere M, Pistoia L, Mangione M, Cuccia L, Spasiano A, Maffei S, Cadeddu C, Midiri M, Borgna C, Meloni A; Working Group of Gender Medicine of Italian Society of Cardiology. Pepe A, et al. Among authors: midiri m. Br J Haematol. 2018 Mar;180(6):879-888. doi: 10.1111/bjh.15125. Epub 2018 Feb 7. Br J Haematol. 2018. PMID: 29504129 Free article. Clinical Trial.
Genotypic groups as risk factors for cardiac magnetic resonance abnormalities and complications in thalassemia major: a large, multicentre study.
Pistoia L, Meloni A, Ricchi P, Filosa A, Lisi R, Maggio A, Rosso R, Messina G, Iacono ND, Cuccia L, Campisi S, Missere M, Midiri M, Vallone A, Renne S, Schicchi N, Righi R, Mangione M, Positano V, Pepe A. Pistoia L, et al. Among authors: midiri m. Blood Transfus. 2021 Mar;19(2):168-176. doi: 10.2450/2020.0023-20. Epub 2020 Jul 22. Blood Transfus. 2021. PMID: 33000750 Free PMC article.
National networking in rare diseases and reduction of cardiac burden in thalassemia major.
Pepe A, Pistoia L, Gamberini MR, Cuccia L, Lisi R, Cecinati V, Maggio A, Sorrentino F, Filosa A, Rosso R, Messina G, Missere M, Righi R, Renne S, Vallone A, Dalmiani S, Positano V, Midiri M, Meloni A. Pepe A, et al. Among authors: midiri m. Eur Heart J. 2022 Jul 7;43(26):2482-2492. doi: 10.1093/eurheartj/ehab851. Eur Heart J. 2022. PMID: 34907420
Deferasirox, deferiprone and desferrioxamine treatment in thalassemia major patients: cardiac iron and function comparison determined by quantitative magnetic resonance imaging.
Pepe A, Meloni A, Capra M, Cianciulli P, Prossomariti L, Malaventura C, Putti MC, Lippi A, Romeo MA, Bisconte MG, Filosa A, Caruso V, Quarta A, Pitrolo L, Missere M, Midiri M, Rossi G, Positano V, Lombardi M, Maggio A. Pepe A, et al. Among authors: midiri m. Haematologica. 2011 Jan;96(1):41-7. doi: 10.3324/haematol.2009.019042. Epub 2010 Sep 30. Haematologica. 2011. PMID: 20884710 Free PMC article.
Cardiac and hepatic iron and ejection fraction in thalassemia major: multicentre prospective comparison of combined deferiprone and deferoxamine therapy against deferiprone or deferoxamine monotherapy.
Pepe A, Meloni A, Rossi G, Cuccia L, D'Ascola GD, Santodirocco M, Cianciulli P, Caruso V, Romeo MA, Filosa A, Pitrolo L, Putti MC, Peluso A, Campisi S, Missere M, Midiri M, Gulino L, Positano V, Lombardi M, Ricchi P. Pepe A, et al. Among authors: midiri m. J Cardiovasc Magn Reson. 2013 Jan 16;15(1):1. doi: 10.1186/1532-429X-15-1. J Cardiovasc Magn Reson. 2013. PMID: 23324167 Free PMC article.
448 results